Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …

We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the
past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely …

Primary aldosteronism (PA) due to a unilateral aldosterone-producing adenoma is a
common cause of hypertension. This can be cured, or greatly improved, by adrenal surgery …

Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …

Primary aldosteronism, or Conn syndrome, is the most common endocrine cause of
hypertension. It is associated with a higher risk of cardiovascular, metabolic and renal …

Context The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio
(ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual …

Objective The aim of this study is to evaluate performance of aldosterone-to-renin ratio
(ARR) before washout of antihypertensive drugs as a screening test for primary …

Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary
hypertension. It is characterized by an overproduction of aldosterone, leading to …

Background An updated understanding of global prevalence of primary aldosteronism (PA)
is essential for the development of primary prevention and management strategies for PA …

Introduction Low-renin hypertension is an underrecognized subtype of hypertension with
specific treatment options. This study aims to identify the prevalence in primary care and to …